OncoGenex Pharmaceuticals, Inc. (OGXI) Tops Q3 EPS by 9c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts OGXI Hot Sheet
Join SI Premium – FREE
OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) reported Q3 EPS of ($0.40), $0.09 better than the analyst estimate of ($0.49). Revenue for the quarter came in at $6.57 million versus the consensus estimate of $4.52 million.
For earnings history and earnings-related data on OncoGenex Pharmaceuticals, Inc. (OGXI) click here.
For earnings history and earnings-related data on OncoGenex Pharmaceuticals, Inc. (OGXI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AIR Global sets first-ever dividend, $100M buyback amid business, cash strength
- Slew of analyst comments sends Take-Two (TTWO) up 4% ahead of November earnings and GTV 6
- Cohen & Steers (CNS) Misses Q3 EPS by 3c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
